Search
Close this search box.

Therapeutic Oligonucleotides Production: CMC – Regulatory – Quality

Organization:
United States Pharmacopeial Convention
NIIMBL Funded:
No
Type:
Professional Development / Training
Relevant Technologies:
Analytical Methods / Technologies
Delivery Modalities:
Online/E-Learning
Type of Enterprise:
Tier 1/Tier 2
Contact:
[email protected]
Location:
Middle Atlantic
Duration:
0-1 Week
Description:
There is an increasing number of oligonucleotides reaching late stage clinical development. For that reason, there is considerable interest in integrated approaches to manufacturing and quality systems towards global product registrations…